JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB227822

Anti-n-Myc/MYCN antibody [EPR18982-8R-3] - ChIP Grade

Be the first to review this product! Submit a review

|

(7 Publications)

Rabbit Recombinant Monoclonal N-Myc/MYCN antibody. Suitable for IP, ChIP, WB and reacts with Human samples. Cited in 7 publications.

View Alternative Names

BHLHE37, NMYC, MYCN, N-myc proto-oncogene protein, Class E basic helix-loop-helix protein 37, bHLHe37

3 Images
Immunoprecipitation - Anti-n-Myc/MYCN antibody [EPR18982-8R-3] - ChIP Grade (AB227822)
  • IP

Unknown

Immunoprecipitation - Anti-n-Myc/MYCN antibody [EPR18982-8R-3] - ChIP Grade (AB227822)

n-Myc/MYCN was immunoprecipitated from 0.35 mg of IMR-32 (human neuroblastoma neuroblast cell line) whole cell lysate with ab227822 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab227822 at 1/500 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/1000 dilution.

Lane 1 : IMR-32 whole cell lysate 10 μg (Input).

Lane 2 : ab227822 IP in IMR-32 whole cell lysate.

Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab227822 in IMR-32 whole cell lysate

Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 3 seconds.

The expression profile observed is consistent with what has been described in the literature (PMID : 17938259; PMID : 2657399).

All lanes:

Immunoprecipitation - Anti-n-Myc/MYCN antibody [EPR18982-8R-3] - ChIP Grade (ab227822)

Predicted band size: 50 kDa

Observed band size: 49-62 kDa

false

ChIP - Anti-n-Myc/MYCN antibody [EPR18982-8R-3] - ChIP Grade (AB227822)
  • ChIP

Unknown

ChIP - Anti-n-Myc/MYCN antibody [EPR18982-8R-3] - ChIP Grade (AB227822)

Chromatin was prepared from IMR-32 cells according to the Abcam X-ChIP protocol. Cells were fixed with formaldehyde for 10min. The ChIP was performed with 25 μg of chromatin, 5 μg of ab227822 (red), and 20 μl of Protein A/G sepharose beads. 5 μg of rabbit normal IgG was added to the beads control (gray). The immunoprecipitated DNA was quantified by real time PCR (SYBR green approach). Primers and probes are located in the first kb of the transcribed region.

Western blot - Anti-n-Myc/MYCN antibody [EPR18982-8R-3] - ChIP Grade (AB227822)
  • WB

Unknown

Western blot - Anti-n-Myc/MYCN antibody [EPR18982-8R-3] - ChIP Grade (AB227822)

Blocking and dilution buffer : 5% NFDM/TBST

The expression profile observed is consistent with what has been described in the literature (PMID : 11034201; PMID : 27197171; PMID : 23792191).

Negative control : HeLa (PMID : 27197171).

All lanes:

Western blot - Anti-n-Myc/MYCN antibody [EPR18982-8R-3] - ChIP Grade (ab227822) at 1/1000 dilution

Lane 1:

IMR-32 (human neuroblastoma neuroblast cell line) whole cell lysate at 20 µg

Lane 2:

HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 50 kDa

Observed band size: 62 kDa

false

Exposure time: 103s

  • Carrier free

    Anti-n-Myc/MYCN antibody [EPR18982-8R-3] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR18982-8R-3

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, IP, ChIP

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "ChIP" : {"fullname" : "ChIP", "shortname":"ChIP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p>", "ChIP-species-checked": "testedAndGuaranteed", "ChIP-species-dilution-info": "5 µg for 25 µg chromatin", "ChIP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p>", "ChIP-species-checked": "notRecommended", "ChIP-species-dilution-info": "", "ChIP-species-notes": "", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 49% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

N-Myc also known as MYCN is a transcription factor encoded by the MYCN gene. It plays an important role in cell proliferation and differentiation. The n-Myc protein is part of the Myc family of transcription factors including c-Myc and c-Myb. n-Myc has a molecular weight of approximately 64 kDa. This protein expresses predominantly in developing tissues particularly in the brain but its expression is seen in other tissues during embryogenesis as well. This characteristic makes it important in early development and organ formation.
Biological function summary

N-Myc/MYCN functions in gene regulation by binding to E-box sequences in DNA facilitating transcription of genes essential for cellular growth and metabolism. n-Myc often forms a heterodimer with the MAX protein which enhances its DNA-binding capacity and transcriptional activity. This activity influences processes like apoptosis cell differentiation and cell cycle progression. The ncm mouse model a genetically engineered mouse with MYCN overexpression demonstrates the effects of deregulated n-Myc expression.

Pathways

MYCN significantly impacts the p53 signaling pathway and the Wnt signaling pathway. In the p53 signaling pathway n-Myc interacts with p53 and MDM2 regulating cell cycle checkpoints and apoptosis. In the Wnt pathway MYCN interplays with molecules like β-catenin to influence cell division and differentiation. These interactions highlight the role of n-Myc in maintaining cellular homeostasis and response to external signals that affect growth and division.

N-Myc is closely linked to neuroblastoma and medulloblastoma aggressive forms of pediatric cancers. MYCN amplification often indicates a poor prognosis in neuroblastoma playing a role in tumor progression and resistance to therapy. In medulloblastoma overexpression of n-Myc partners with proteins like Aurora A kinase to promote oncogenesis. Targeting these protein interactions offers potential therapeutic strategies for these MYCN-related cancers.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Positively regulates the transcription of MYCNOS in neuroblastoma cells.
See full target information MYCN

Publications (7)

Recent publications for all applications. Explore the full list and refine your search

Cell death & disease 16:470 PubMed40593489

2025

PKIB facilitates bladder cancer proliferation and metastasis through mediation of HSP27 phosphorylation by PKA.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaolong Liu,Xiaoyu Yin,Feng Yuan,Shiqing Li,Fei Xiao,Feng Zhou,Xudong Pan,Yatfaat Ho,Shuo Dong,Duan Xu,Yunqing Ma,Zhengding Cao,Zhe Lei,Yi Sun

Ophthalmology science 5:100820 PubMed40529103

2025

Diminished MYCN Dosage Endows Cavitary Transformation in Retinoblastoma.

Applications

Unspecified application

Species

Unspecified reactive species

Mingpeng Xu,Hanhan Shi,Yongning Shen,Ludi Yang,Yu Luan,Xiang Gu,Xuyang Wen,Chuandi Zhou,Renbing Jia,Xunda Ji,Peiquan Zhao,Minglei Han,Jiayan Fan,Peiwei Chai

eNeuro : PubMed39694827

2024

Inhibition of Pyroptosis by Hydroxychloroquine as a Neuroprotective Strategy in Ischemic Stroke.

Applications

Unspecified application

Species

Unspecified reactive species

Wenshuo Peng,Kaiming Guo,Jian Hu,Qianchun Wang

Molecular oncology 19:741-763 PubMed39021294

2024

Sustained cancer-relevant alternative RNA splicing events driven by PRMT5 in high-risk neuroblastoma.

Applications

Unspecified application

Species

Unspecified reactive species

Laurel Tabe Bate-Eya,Gulsah Albayrak,Simon Mark Carr,Amit Shrestha,Alexander Kanapin,Anastasia Samsonova,Nicholas Barrie La Thangue

iScience 27:108706 PubMed38288355

2024

Sirt6 regulates the proliferation of neural precursor cells and cortical neurogenesis in mice.

Applications

Unspecified application

Species

Unspecified reactive species

Yufei Wei,Xinhuan Wang,Zhihua Ma,Pan Xiang,Gaoao Liu,Bin Yin,Lin Hou,Pengcheng Shu,Wei Liu,Xiaozhong Peng

Cancer gene therapy 30:149-162 PubMed36123390

2022

YAP 5-methylcytosine modification increases its mRNA stability and promotes the transcription of exosome secretion-related genes in lung adenocarcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Wenjun Yu,Congcong Zhang,Yikun Wang,Xiaoting Tian,Yayou Miao,Fanyu Meng,Lifang Ma,Xiao Zhang,Jinjing Xia

Frontiers in medicine 9:942991 PubMed36016998

2022

A prognosis model for clear cell renal cell carcinoma based on four necroptosis-related genes.

Applications

Unspecified application

Species

Unspecified reactive species

Qiangmin Qiu,Yanze Li,Ye Zhang,Yanguang Hou,Juncheng Hu,Lei Wang,Zhiyuan Chen,Yourong Lei,Yang Du,Xiuheng Liu
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com